Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation

被引:1
|
作者
Niwa, Toshiro [1 ]
Sasaki, Shoko [1 ]
Yamamoto, Yuka [1 ]
Tanaka, Mayu [1 ]
机构
[1] Shujitsu Univ, Sch Pharm, Naka Ku, 1-6-1 Nishigawara, Okayama 7038516, Japan
关键词
DOPAMINE FORMATION; GENETIC-POLYMORPHISM; STEROID-HORMONES; P-TYRAMINE; OXIDATION; SUBSTRATE; ALLOPREGNANOLONE; NEUROSTEROIDS; METABOLISM; ENZYMES;
D O I
10.1007/s13318-022-00784-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objectives Herein, hydroxylation activities at the 6 beta-position and 21-position of progesterone mediated by human cytochrome P450 (CYP) 2D6 and its variants and the effects of psychotropic drugs on these hydroxylation activities were compared to clarify whether CYP2D6 polymorphisms and psychotropic drugs impact neurosteroid levels in the brain. Methods Progesterone was incubated with CYP2D6.1, CYP2D6.2 (Arg296Cys, Ser486Thr), CYP2D6.10 (Pro34Ser, Ser486Thr), and CYP2D6.39 (Ser486Thr) in the absence or presence of typical psychotropic drugs (fluvoxamine, fluoxetine, paroxetine, fluphenazine, and milnacipran) and endogenous steroids (testosterone and cortisol). Then, 6 beta- and 21-hydroxyprogesterone levels were determined by high-performance liquid chromatography. Results Although the Michaelis-Menten constants (K-m) for progesterone 6 beta- and 21-hydroxylation reactions mediated by the different CYP2D6 variants were similar, the maximal velocity (V-max) values of the reactions mediated by CYP2D6.1 and CYP2D6.2 were the highest, followed by those mediated by CYP2D6.39 and CYP2D6.10. Thus, the of progesterone 6 beta- and/or 21-hydroxylation reactions mediated by CYP2D6.1 and CYP2D6.2 showed the highest V-max/K-m values, followed by the reactions mediated by CYP2D6.39. All investigated compounds inhibited progesterone 21-hydroxylation mediated by CYP2D6 variants at high concentrations. Interestingly, at low concentrations, fluoxetine increased progesterone 21-hydroxylation mediated by CYP2D6.1, but not that mediated by CYP2D6.2 or CYP2D6.10. In addition, the K-m value for CYP2D6.2 was elevated in the presence of fluoxetine, whereas the value for CYP2D6.1 was unaltered; however, V-max values of both CYP2D6.1 and CYP2D6.2 were increased. Paroxetine competitively inhibited CYP2D6.1- and CYP2D6.2-mediated progesterone 21-hydroxylation. Conclusions These results suggest that CYP2D6 polymorphism can affect the stimulation/inhibition of progesterone 21-hydroxylation.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 50 条
  • [31] Cytochrome P450 2D6 and treatment of codeine dependence
    Romach, MK
    Otton, SV
    Somer, G
    Tyndale, RF
    Sellers, EM
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (01) : 43 - 45
  • [32] Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6
    Uehara, Shotaro
    Murayama, Norie
    Yamazaki, Hiroshi
    Suemizu, Hiroshi
    XENOBIOTICA, 2019, 49 (11) : 1323 - 1331
  • [33] Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate
    McConnachie, L
    Bodor, M
    Kowdley, K
    Levy, A
    Tung, B
    Thummel, K
    Phillips, B
    Bajpai, M
    Chi, V
    Esmay, JD
    Shen, DA
    Ho, RJY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (04) : 282 - 297
  • [34] Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus
    Paulusova, Vladimira
    Roesch, Christiane
    Drizhal, Ivo
    Perlik, Frantisek
    Masin, Vladimir
    Sukumar, Sujith
    Slezak, Radovan
    Slanar, Ondrej
    ACTA ODONTOLOGICA SCANDINAVICA, 2010, 68 (04) : 193 - 198
  • [35] Cytochrome P450 2D6 Polymorphism Is a Molecular Genetic Marker of Liver Cirrhosis Progression
    Nepomnyashchikh, D. L.
    Vavilin, V. A.
    Aidagulova, S. V.
    Makarova, S. I.
    Karavaeva, Yu Yu
    Shchepotina, E. G.
    Postnikova, O. A.
    Nokhrina, Zh V.
    Vinogradova, E. V.
    Lyakhovich, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 152 (05) : 633 - 636
  • [36] Cytochrome P450 2D6 Polymorphism Is a Molecular Genetic Marker of Liver Cirrhosis Progression
    D. L. Nepomnyashchikh
    V. A. Vavilin
    S. V. Aidagulova
    S. I. Makarova
    Yu. Yu. Karavaeva
    E. G. Shchepotina
    O. A. Postnikova
    Zh. V. Nokhrina
    E. V. Vinogradova
    V. V. Lyakhovich
    Bulletin of Experimental Biology and Medicine, 2012, 152 : 633 - 636
  • [37] Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity
    Bogdanos, DP
    McFarlane, IG
    JOURNAL OF HEPATOLOGY, 2003, 39 (05) : 860 - 863
  • [38] Genetic Polymorphism of Cytochrome P450 2D6*4 and 2D6*5 in an Adult Population Sample from Costa Rica
    Chaverri-Fernandez, Jose Miguel
    Ortiz-Urena, Angie
    Pablo, Diaz-Madriz Jose
    Alvarado-Leiton, Jeimy
    Garcia-Chaves, Sergio
    Garro-Zamora, Luis David
    Arias-Echandi
    Laura, Maria
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2016, 16 (1-2) : 10 - 15
  • [39] Cytochrome P450 2D6 inhibitory constituents of Lunasia amara
    Takahashi, Subehan Naoto
    Kadota, Shigetoshi
    Tezuka, Yasuhiro
    PHYTOCHEMISTRY LETTERS, 2011, 4 (01) : 30 - 33
  • [40] Antidepressant drugs in the elderly - Role of the cytochrome P450 2D6
    Vandel, P
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (02): : 74 - 80